Zusammenfassung
Die Bestrahlung des Gehirns ist ein wichtiges Verfahren in der Behandlung maligner und benigner Erkrankungen mit zerebraler Beteiligung. Der mögliche akute oder chronische Einfluss auf kognitive Leistungen ist für die Alltagskompetenz und Lebensqualität der Patienten wichtig und muss gemeinsam mit einer primären Kontrolle der Erkrankungsprogression differenziert bewertet werden. Die Strahlensensibilität des Hippocampus und seine Bedeutung für Gedächtnisleistungen sind ein Beispiel dafür, dass kognitionsprotektive Strategien im Rahmen der Behandlungsplanung eine hohe Präzision der Therapieverfahren voraussetzen.
Abstract
Brain radiation is an important treatment option for malignant and benign brain diseases. The possible acute or chronic impact of radiation therapy on cognitive performance is important for daily functioning and quality of life. A detailed evaluation of cognitive impairment is important in the context of how to control disease progression. The susceptibility of the hippocampus to radiation-induced neuronal damage and its important role in memory highlight that therapeutic strategies require precision medicine.
Literatur
Robert Koch Institut (2015) Beiträge zur Gesundheitsberichterstattung des Bundes: „Krebs in Deutschland“, 2011/2012
Jacola LM et al (2016) Cognitive, behaviour, and academic functioning in adolescent and young adult survivors of childhood acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study. Lancet Psychiatry 3(10):965–972
Sabater A et al (2016) Comparative neurocognitive effects of lithium and anticonvulsants in long-term stable bipolar patients. J Affect Disord 190:34
Bodensohn R et al (2016) A prospective study on neurocognitive effects after primary radiotherapy in high-grade glioma patients. Int J Clin Oncol 21(4):642–650
Clanton NR et al (2011) Fatigue, vitality, sleep, and neurocognitive functioning in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer 117(11):2559–2568
Mohn C, Rund BR (2016) Neurocognitive profile in major depressive disorders: relationship to symptom level and subjective memory complaints. BMC Psychiatry 16:108. https://doi.org/10.1186/s12888-016-0815-8
Li J et al (2008) Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis. Int J Radiat Oncol Biol Phys 71(1):64–70
Li J, Bentzen SM, Renschler M, Mehta MP (2007) Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol 25(10):1260–1266
Burgess N, Maguire EA, O’keefe J (2002) The human hippocampus and spatial and episodic memory. Neuron 35(4):625–641
Tofilon PJ, Fike JR (2000) The radioresponse of the central nervous system: a dynamic process. Radiat Res 153(4):357–370
Welzel G et al (2008) Acute neurocognitive impairment during cranial radiation therapy in patients with intracranial tumors. Strahlenther Onkol 184(12):647–654
Greene-Schloesser D et al (2012) Radiation-induced brain injury: a review. Front Oncol 2:73. https://doi.org/10.3389/fonc.2012.00073
Lee YW, Cho HJ, Lee WH, Sonntag WE (2012) Whole brain radiation-induced cognitive impairment: pathophysiological mechanisms and therapeutic targets. Biomol Ther (Seoul) 20(4):357–370
Coderre JA et al (2006) Late effects of radiation on the central nervous system: role of vascular endothelial damage and glial stem cell survival. Radiat Res 166(3):495–503
Molad JA et al (2017) Mechanisms of post-radiation injury: cerebral microinfarction not a significant factor. J Neurooncol 131(2):277–281
Lai R, Abrey LE, Rosenblum MK, Deangelis LM (2004) Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study. Neurology 62(3):451–456
Baker DG, Krochak RJ (1989) The response of the microvascular system to radiation: a review. Cancer Invest 7(3):287–294
Mcgeer EG, Klegeris A, Mcgeer PL (2005) Inflammation, the complement system and the diseases of aging. Neurobiol Aging 26(Suppl):194–197
Querfurth HW, Laferla FM (2010) Alzheimer’s disease. N Engl J Med 362(4):329–344
Meyers CA, Wefel JS (2003) The use of the mini-mental state examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity. J Clin Oncol 21(19):3557–3558
Armstrong C et al (1995) Biphasic patterns of memory deficits following moderate-dose partial-brain irradiation: neuropsychologic outcome and proposed mechanisms. J Clin Oncol 13(9):2263–2271
Klein M et al (2002) Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 360(9343):1361–1368
Douw L et al (2009) Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. Lancet Neurol 8(9):810–818
Correa DD et al (2008) Longitudinal cognitive follow-up in low grade gliomas. J Neurooncol 86(3):321–327
Postma TJ et al (2002) Radiotherapy-induced cerebral abnormalities in patients with low-grade glioma. Neurology 59(1):121–123
Surma-Aho O et al (2001) Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients. Neurology 56(10):1285–1290
Olson JD, Riedel E, Deangelis LM (2000) Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology 54(7):1442–1448
Laack NN et al (2005) Cognitive function after radiotherapy for supratentorial low-grade glioma: a North Central Cancer Treatment Group prospective study. Int J Radiat Oncol Biol Phys 63(4):1175–1183
Torres IJ et al (2003) A longitudinal neuropsychological study of partial brain radiation in adults with brain tumors. Neurology 60(7):1113–1118
Vigliani MC, Sichez N, Poisson M, Delattre JY (1996) A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4‑year results. Int J Radiat Oncol Biol Phys 35(3):527–533
Keime-Guibert F et al (2007) Radiotherapy for glioblastoma in the elderly. N Engl J Med 356(15):1527–1535
Flechl B et al (2012) Neurocognitive and sociodemographic functioning of glioblastoma long-term survivors. J Neurooncol 109(2):331–339
Scoccianti S et al (2012) Changes in neurocognitive functioning and quality of life in adult patients with brain tumors treated with radiotherapy. J Neurooncol 108(2):291–308
Shah AJ et al (2008) Progressive declines in neurocognitive function among survivors of hematopoietic stem cell transplantation for pediatric hematologic malignancies. J Pediatr Hematol Oncol 30(6):411–418
Chang EL et al (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10(11):1037–1044
Brown PD et al (2016) Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial. JAMA 316(4):401–409
Aoyama H et al (2007) Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 68(5):1388–1395
Sun A et al (2011) Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis. J Clin Oncol 29(3):279–286
Kiebert GM et al (1998) Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group. Eur J Cancer 34(12):1902–1909
Gondi V, Hermann BP, Mehta MP, Tome WA (2013) Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors. Int J Radiat Oncol Biol Phys 85(2):348–354
Tsai PF et al (2015) Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study. Radiat Oncol 10:253. https://doi.org/10.1186/s13014-015-0562-x
Mizumatsu S et al (2003) Extreme sensitivity of adult neurogenesis to low doses of X‑irradiation. Cancer Res 63(14):4021–4027
Monje ML, Mizumatsu S, Fike JR, Palmer TD (2002) Irradiation induces neural precursor-cell dysfunction. Nat Med 8(9):955–962
Tang FR, Loke WK, Khoo BC (2017) Postnatal irradiation-induced hippocampal neuropathology, cognitive impairment and aging. Brain Dev 39(4):277–293
Parihar VK, Limoli CL (2013) Cranial irradiation compromises neuronal architecture in the hippocampus. Proc Natl Acad Sci U S A 110(31):12822–12827
Monje ML, Toda H, Palmer TD (2003) Inflammatory blockade restores adult hippocampal neurogenesis. Science 302(5651):1760–1765
Raber J et al (2004) Radiation-induced cognitive impairments are associated with changes in indicators of hippocampal neurogenesis. Radiat Res 162(1):39–47
Acharya MM et al (2009) Rescue of radiation-induced cognitive impairment through cranial transplantation of human embryonic stem cells. Proc Natl Acad Sci U S A 106(45):19150–19155
Pospisil P et al (2015) Hippocampal proton MR spectroscopy as a novel approach in the assessment of radiation injury and the correlation to neurocognitive function impairment: initial experiences. Radiat Oncol 10:211
Pospisil P et al (2017) Post-WBRT cognitive impairment and hippocampal neuronal depletion measured by in vivo metabolic MR spectroscopy: results of prospective investigational study. Radiother Oncol 122(3):373–379
Seibert TM et al (2017) Radiation dose-dependent hippocampal atrophy detected with longitudinal volumetric magnetic resonance imaging. Int J Radiat Oncol Biol Phys 97(2):263–269
Gondi V et al (2014) Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. J Clin Oncol 32(34):3810–3816
Lin SY et al (2015) Evaluating the impact of hippocampal sparing during whole brain radiotherapy on neurocognitive functions: a preliminary report of a prospective phase II study. Biomed J 38(5):439–449
Munck Af Rosenschold P et al (2011) Photon and proton therapy planning comparison for malignant glioma based on CT, FDG-PET, DTI-MRI and fiber tracking. Acta Oncol 50(6):777–783
Kazda T et al (2014) Why and how to spare the hippocampus during brain radiotherapy: the developing role of hippocampal avoidance in cranial radiotherapy. Radiat Oncol 9:139. https://doi.org/10.1186/1748-717X-9-139
Correa DD et al (2016) Cognitive effects of donepezil therapy in patients with brain tumors: a pilot study. J Neurooncol 127(2):313–319
Shaw EG et al (2006) Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol 24(9):1415–1420
Rapp SR et al (2015) Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. J Clin Oncol 33(15):1653–1659
Brown PD et al (2013) Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-oncology 15(10):1429–1437
Yazlovitskaya EM et al (2006) Lithium treatment prevents neurocognitive deficit resulting from cranial irradiation. Cancer Res 66(23):11179–11186
Donix M, Bauer M (2016) Population studies of association between lithium and risk of neurodegenerative disorders. Curr Alzheimer Res 13(8):873–878
Xia F, Yang E, Hallahan D, Lu B (2008) Lithium-mediated neuroprotection during cranial irradiation: a phase I trial. Neuro-oncology 10(5):887
Thotala D et al (2015) Valproic acid enhances the efficacy of radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells. Oncotarget 6(33):35004–35022
Tommasino F, Durante M (2015) Proton radiobiology. Cancers 7(1):353–381
Mohan R, Grosshans D (2017) Proton therapy – present and future. Adv Drug Deliv Rev 109:26–44
Harrabi SB et al (2016) Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma. Strahlenther Onkol 192(11):759–769
Eaton BR, Yock T (2014) The use of proton therapy in the treatment of benign or low-grade pediatric brain tumors. Cancer J 20(6):403–408
Kahalley LS et al (2016) Comparing intelligence quotient change after treatment with proton versus photon radiation therapy for pediatric brain tumors. J Clin Oncol 34(10):1043–1049
Pulsifer MB et al (2015) Early cognitive outcomes following proton radiation in pediatric patients with brain and central nervous system tumors. Int J Radiat Oncol Biol Phys 93(2):400–407
Shih HA et al (2015) Proton therapy for low-grade gliomas: results from a prospective trial. Cancer 121(10):1712–1719
Sherman JC et al (2016) Neurocognitive effects of proton radiation therapy in adults with low-grade glioma. J Neurooncol 126(1):157–164
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
M. Buthut, R. Haussmann, A. Seidlitz, M. Krause und M. Donix geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Buthut, M., Haussmann, R., Seidlitz, A. et al. Kognitive Defizite nach Strahlentherapie von Hirntumoren. Nervenarzt 89, 423–430 (2018). https://doi.org/10.1007/s00115-017-0423-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00115-017-0423-y